Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance — VISION Network, 10 States, August 2021

Thompson, Mark G.Natarajan, KarthikIrving, Stephanie A.Rowley, Elizabeth A.Griggs, Eric P.Gaglani, ManjushaKlein, Nicola P.Grannis, Shaun J.DeSilva, Malini B.Stenehjem, EdwardReese, Sarah E.Dickerson, MonicaNaleway, Allison L.Han, JungmiKonatham, DeepikaMcEvoy, CharleneRao, SuchitraDixon, Brian E.Dascomb, KristinLewis, NedLevy, Matthew E.Patel, PalakLiao, I-ChiaKharbanda, Anupam B.Barron, Michelle A.Fadel, William F.Grisel, NancyGoddard, KristinYang, Duck-HyeWondimu, Mehiret H.Murthy, KempapuraValvi, Nimish R.Arndorfer, JulieFireman, BruceDunne, Margaret M.Embi, PeterAzziz-Baumgartner, EduardoZerbo, OussenyBozio, Catherine H.Reynolds, SueFerdinands, JillWilliams, JeremiahLink-Gelles, RuthSchrag, Stephanie J.Verani, Jennifer R.Ball, SarahOng, Toan C.2024-06-212024-06-212022-01-28Thompson, M. G. (2022). Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance—VISION Network, 10 States, August 2021–January 2022. MMWR. Morbidity and Mortality Weekly Report, 71. https://doi.org/10.15585/mmwr.mm7104e3https://hdl.handle.net/1805/41747en-USPublisher PolicyCOVID-19mRNAvaccine effectiveness (VE)SARS-CoV-2 variantsEffectiveness of a Third Dose of mRNA Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance — VISION Network, 10 States, August 2021–January 2022Article